Skip to main content

Joseph Talanges Appointed President and COO of GC America

MI Paste® ONE Perio

One Step Anti-Gingivitis Toothpaste with RECALDENT® Technology

GC Initial® LiSi Block

Lithium Disilicate Glass Ceramic CAD/CAM Block

G-ænial™ A’CHORD

Universal Light-Cured Radiopaque Composite Restorative

G-CEM ONE™

Universal Self-Adhesive Resin Cement

GC Initial® LiSi Press

High Strength Lithium Disilicate with HDM Technology

EQUIA Forte® HT

Cost-Effective Long Term Restorative Alternative

Joseph Talanges Appointed President and COO of GC America

A photo of Joseph Talanges

GC America is excited to announce the appointment of Joe Talanges as the new President and Chief Operating Officer of GC America as of December 12, 2022, bringing his 30 years of med-tech and biopharma industry knowledge across multiple countries and continents to his new role. As President and COO of GC America, Talanges will be responsible for leading all operating, development and commercial functions and accelerating growth across the region and focus on key markets in The Americas including the United States, Canada, Mexico, and Brazil.

Talanges has significant experience transforming several businesses to accelerated growth and possesses considerable U.S. and global life science industry P&L experience, business strategy, sales and marketing leadership, innovation, mergers and acquisitions, and new product launches. His professional background includes senior leadership roles across The Americas, Europe, Middle East and Africa with Abbott, Hospira, Pfizer and ConvaTec.